(Q36918546)

English

13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cells

scientific article published on 27 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cells (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Xiao-Fei Ding

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Mao Shen

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Li-Ying Xu

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jin-Hua Dong

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Guang Chen

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

27 February 2013

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Oncology Letters

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1554-1558

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Autophagy as a target for cancer therapy: new developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Molecular mechanisms of mTOR-mediated translational control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

The biology behind mTOR inhibition in sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Defining the role of mTOR in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

The role of natural product chemistry in drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Phase III clinical trial of elemenum emulsion in the management of malignant pleural and peritoneal effusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

29 September 2017

[Clinical study on treatment of 40 cases of malignant brain tumor by elemene emulsion injection].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3678516

4 September 2018

In vitro cytotoxicity of salvicine, a novel diterpenoid quinone

1 reference

https://pubmed.ncbi.nlm.nih.gov/23761818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23761818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Isolation and identification of elemene from the essential oil of Curcuma wenyujin]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23761818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/OL.2013.1213

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36918546&oldid=1663209132"